Balance Sheet
Accounts PayablesAccumulated ExpensesCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent TaxesGoodwill & IntangiblesInventoryLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zhengye Biotechnology Holding (ZYBT) Non-Current Debt: 2023-2025

  • Zhengye Biotechnology Holding's Non-Current Debt was N/A to $649,788 in Q2 2025 from the same period last year, while for Jun 2025 it was $649,788, marking a year-over-year change of. This contributed to the annual value of $658,000 for FY2024, which is 53.45% down from last year.
  • Latest data reveals that Zhengye Biotechnology Holding reported Non-Current Debt of $649,788 as of Q2 2025, which was down 1.25% from $658,000 recorded in Q4 2024.
  • Zhengye Biotechnology Holding's 5-year Non-Current Debt high stood at $1.4 million for Q4 2023, and its period low was $649,788 during Q2 2025.
  • Its 3-year average for Non-Current Debt is $898,424, with a median of $658,000 in 2024.
  • Data for Zhengye Biotechnology Holding's Non-Current Debt shows a maximum YoY plummeted of 52.58% (in 2024) over the last 5 years.
  • Quarterly analysis of 3 years shows Zhengye Biotechnology Holding's Non-Current Debt stood at $1.4 million in 2023, then tumbled by 52.58% to $658,000 in 2024, then reached $649,788 in 2025.
  • Its last three reported values are $649,788 in Q2 2025, $658,000 for Q4 2024, and $1.4 million during Q4 2023.